Inventor

Yanbin Lao

Inventor
Abbott Park, IL, US

Overview

14→
Patents
2011–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 14 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
11,091,507Methods of treating Parkinson's disease202110,174,061Carbidopa and L-dopa prodrugs and methods of use20199,656,955'Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,650,334'Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,586,945'Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,586,942'Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,550,754'4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy'20179,446,059'Carbidopa and L-dopa prodrugs and methods of use'20169,150,545'Carboxamide compounds and their use as calpain inhibitors V'20159,062,027'Carboxamide compounds and their use as calpain inhibitors V'20159,051,304'Carboxamide compounds and their use as calpain inhibitors V'20158,598,211'Carboxamide compounds and their use as calpain inhibitors IV'20138,343,959'N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'20138,076,326'N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2015Patents assigned to BACKFISCH GISELA (5)· patent assignee history
2011–2015Patents assigned to LAO YANBIN (5)· patent assignee history
2011–2017Based in Abbott Park, IL, US· patent location history
2013–2021Patents assigned to ABBVIE INC (12)· patent assignee history
2013–2017Patents assigned to ABBVIE DEUTSCHLAND (9)· patent assignee history
2013–2015Patents assigned to HORNBERGER WILFRIED (3)· patent assignee history
2015–2017Based in North Chicago, IL, US· patent location history
2016–2021Based in Lake Bluff, IL, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ABBVIE INC122013–2021
ABBVIE DEUTSCHLAND92013–2017
BACKFISCH GISELA52011–2015
LAO YANBINself52011–2015
HORNBERGER WILFRIED32013–2015
Locations
LocationPatentsSpan
Abbott Park, Illinois, US62011–2017
North Chicago, Illinois, US52015–2017
Lake Bluff, Illinois, US32016–2021